Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TGFBR2 Antikörper (AA 25-159)

TGFBR2 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7171961
  • Target Alle TGFBR2 Antikörper anzeigen
    TGFBR2 (Transforming Growth Factor, beta Receptor II (70/80kDa) (TGFBR2))
    Bindungsspezifität
    • 29
    • 16
    • 15
    • 14
    • 11
    • 11
    • 8
    • 7
    • 7
    • 7
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 25-159
    Reaktivität
    • 113
    • 95
    • 53
    • 22
    • 20
    • 7
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 132
    • 7
    • 5
    • 5
    • 2
    Kaninchen
    Klonalität
    • 143
    • 7
    • 1
    Polyklonal
    Konjugat
    • 61
    • 12
    • 9
    • 9
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    Dieser TGFBR2 Antikörper ist unkonjugiert
    Applikation
    • 108
    • 56
    • 39
    • 39
    • 34
    • 21
    • 19
    • 18
    • 11
    • 9
    • 4
    • 2
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human TGF-beta receptor type-2 protein (25-159AA)
    Isotyp
    IgG
    Top Product
    Discover our top product TGFBR2 Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    TGFBR2 (Transforming Growth Factor, beta Receptor II (70/80kDa) (TGFBR2))
    Andere Bezeichnung
    TGFBR2 (TGFBR2 Produkte)
    Synonyme
    AAT3 antikoerper, FAA3 antikoerper, LDS1B antikoerper, LDS2B antikoerper, MFS2 antikoerper, RIIC antikoerper, TAAD2 antikoerper, TGFR-2 antikoerper, TGFbeta-RII antikoerper, 1110020H15Rik antikoerper, AU042018 antikoerper, DNIIR antikoerper, RIIDN antikoerper, TBR-II antikoerper, TbetaR-II antikoerper, TbetaRII antikoerper, TGFBR2 antikoerper, TBETA-RII antikoerper, TGFBRII antikoerper, TGF-beta 2 antikoerper, Tgfbr2T antikoerper, cb537 antikoerper, tgfbr2 antikoerper, wu:fj05c10 antikoerper, zgc:110498 antikoerper, transforming growth factor beta receptor 2 antikoerper, transforming growth factor, beta receptor II antikoerper, transforming growth factor, beta receptor 2 antikoerper, transforming growth factor beta receptor 2b antikoerper, TGFBR2 antikoerper, Tgfbr2 antikoerper, tgfbr2b antikoerper
    Hintergrund

    Background: Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 Molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.

    Aliases: AAT3 antibody, FAA3 antibody, LDS1B antibody, LDS2 antibody, LDS2B antibody, MFS2 antibody, RIIC antibody, TAAD2 antibody, TbetaR II antibody, TbetaR-II antibody, TGF beta receptor type 2 antibody, TGF beta receptor type II antibody, TGF beta receptor type IIB antibody, TGF beta type II receptor antibody, TGF-beta receptor type II antibody, TGF-beta receptor type-2 antibody, TGF-beta type II receptor antibody, TGF-beta-R2 antibody, TGFB R2 antibody, TGFbeta - RII antibody, TGFbeta RII antibody, Tgfbr2 antibody, TGFR-2 antibody, TGFR2_HUMAN antibody, Transforming growth factor beta receptor II antibody, Transforming growth factor beta receptor type II antibody, Transforming growth factor beta receptor type IIC antibody, Transforming growth factor, beta receptor II (70/80 kDa) antibody, transforming growth factor, beta receptor II alpha antibody, transforming growth factor, beta receptor II beta antibody, transforming growth factor, beta receptor II delta antibody, transforming growth factor, beta receptor II epsilon antibody, transforming growth factor, beta receptor II gamma antibody, Transforming growth factor-beta receptor type II antibody

    UniProt
    P37173
Sie sind hier: